Listen… We are always on the hunt for a deal. Clothes, restaurants, travel, whatever — if there’s a deal out there, we’ll ...
Over the years, there has been an increasing demand for an effective and cost-efficient drug discovery process. The study of ...
Talks of a trade dispute between the United States and Australia over the cost of medicines have no doubt left many ...
Members of Iowa’s congressional delegation have introduced legislation they say will help lower drug costs.
Over 60% of prescriptions for conditions like hypertension and mental health disorders in the US rely on Indian-made drugs, ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.
The viral post sparked discussion among social media users, one saying: "welcome to the civilized world where health care is ...
Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.
President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...
Employees at banking giant JPMorgan Chase claimed in a new class action suit that the company mismanaged their benefits, ...
Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results